These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 28460024)

  • 21. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
    Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
    Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation.
    Indredavik B; Rohweder G; Lydersen S
    J Intern Med; 2005 Aug; 258(2):133-44. PubMed ID: 16018790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation.
    Tanaka K; Yamada T; Torii T; Furuta K; Matsumoto S; Yoshimura T; Takase K; Wakata Y; Nakashima N; Kira J; Murai H
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1629-35. PubMed ID: 25906940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-vitamin K oral anticoagulants as first-line regimen for acute ischemic stroke with non-valvular atrial fibrillation.
    Park CW; Nam HS; Heo JH; Park HJ; Choi JK; Lee HS; Na HK; Kim YD
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105025. PubMed ID: 32807440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preceding Antithrombotic Treatment is Associated With Acute Ischemic Stroke Severity and Functional Outcome at 90 Days Among Patients With Atrial Fibrillation.
    Yi X; Lin J; Han Z; Luo H; Shao M; Fan D; Zhou Q
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):2003-2010. PubMed ID: 31047821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
    Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
    Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute Ischemic Stroke Outcome and Preceding Anticoagulation: Direct Oral Anticoagulants Versus Vitamin K Antagonists.
    Tavares SF; Ferreira I; Chaves V; Flores L; Correia C; Almeida J; Fonseca L; Castro Chaves P
    J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104691. PubMed ID: 32067853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
    Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with therapeutic anticoagulation status in patients with ischemic stroke and atrial fibrillation.
    Yaghi S; Liberman AL; Henninger N; Grory BM; Nouh A; Scher E; Giles J; Liu A; Nagy M; Kaushal A; Azher I; Fakhri H; Espaillat KB; Asad SD; Pasupuleti H; Martin H; Tan J; Veerasamy M; Esenwa C; Cheng N; Moncrieffe K; Moeini-Naghani I; Siddu M; Trivedi T; Ishida K; Frontera J; Lord A; Furie K; Keyrouz S; de Havenon A; Mistry E; Leon Guerrero CR; Khan M
    J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104888. PubMed ID: 32414583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between stroke severity and prior direct oral anticoagulant therapy in patients with acute ischaemic stroke and non-valvular atrial fibrillation.
    Sakamoto Y; Okubo S; Nito C; Suda S; Matsumoto N; Abe A; Aoki J; Shimoyama T; Takayama Y; Suzuki K; Mishina M; Kimura K
    Eur J Neurol; 2017 Nov; 24(11):1399-1406. PubMed ID: 28799181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of prestroke oral anticoagulation on severity and outcome of ischemic and hemorrhagic stroke in patients with atrial fibrillation.
    Audebert HJ; Schenk B; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2010; 29(5):476-83. PubMed ID: 20299787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alcohol-related hospitalization is associated with increased risk of ischaemic stroke among low-risk patients with atrial fibrillation.
    Al-Khalili F; Benson L; Friberg L
    Europace; 2018 Jan; 20(1):19-24. PubMed ID: 28339885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved late survival and disability after stroke with therapeutic anticoagulation for atrial fibrillation: a population study.
    Hannon N; Callaly E; Moore A; Ní Chróinín D; Sheehan O; Marnane M; Merwick A; Kyne L; Duggan J; McCormack PM; Dolan E; Crispino-O'Connell G; Harris D; Horgan G; Williams D; Kelly PJ
    Stroke; 2011 Sep; 42(9):2503-8. PubMed ID: 21778447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.
    Rillig A; Lin T; Plesman J; Heeger CH; Lemes C; Metzner A; Mathew S; Wissner E; Wohlmuth P; Ouyang F; Kuck KH; Tilz RR
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):147-53. PubMed ID: 26464027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severity and Functional Outcome of Patients with Cardioembolic Stroke Occurring during Non-vitamin K Antagonist Oral Anticoagulant Treatment.
    Tomita H; Hagii J; Metoki N; Saito S; Shiroto H; Hitomi H; Kamada T; Seino S; Takahashi K; Sasaki S; Yasujima M; Okumura K
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1430-7. PubMed ID: 25843224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment Changes among Users of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation.
    Hellfritzsch M; Husted SE; Grove EL; Rasmussen L; Poulsen BK; Johnsen SP; Hallas J; Pottegård A
    Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):187-194. PubMed ID: 27580086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation.
    Tiili P; Leventis I; Kinnunen J; Svedjebäck I; Lehto M; Karagkiozi E; Sagris D; Ntaios G; Putaala J
    Ann Med; 2021 Dec; 53(1):1613-1620. PubMed ID: 34498537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.